Search
for
Sort by
Research 271–300 of 877
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Impact and Management of Loss of Eyebrows and Eyelashes
- Inherited Hairlessness: A Case Study of Familial Congenital Atrichia
- Madarosis and facial keratinaceous spines
- Signposts to the Promised Land in Alopecia Areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders
- An eruption of numerous spiny papules in a pediatric transplant patient
- Frontalna fibrozirajuća alopecija
- Aesthetic Management of Upper and Midface Trauma
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment
- Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV‐infected women with and without central lipohypertrophy
- Onychomadesis associated with childhood hand-foot-mouth disease
- Hair casts
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Eyelashes, eyebrows and pubic hair restoration
- More Yellow Ovaries
- Clinicopathologic Correlate of a Fresh Eyelid Pigment Implantation
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- BC06: Efficacy of lasers and light‐based devices in long‐term hair reduction defined by body site‐specific growth cycles: a systematic review
- A case of familial trichomegaly with synophrys in association with loose anagen syndrome
- Alopecia areata of eyelashes: Regrowth after injecting triamcinolone into the eyebrow area
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- FGF5 is a crucial regulator of hair length in humans
- Hypertrichosis of the eyelashes caused by bimatoprost
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Management of Hypotrichosis of the Eyelashes
- Trichomegaly of the eyelashes following treatment with cetuximab
- Acquired trichomegaly with topiramate